Eight Roads Ventures, the investment arm of Fidelity, has set up a healthcare fund that will focus on Chinese startups in the therapeutics, services, IT and medical technology sectors.

The University of Oxford spinout has filed for an $86.25m initial public offering in the US just three years after being founded.

General Electric and National Football League previously provided funding through the GE NFL Head Health Challenge.

GV and Celgene have returned for a $67m series C1 round in Armo Biosciences, which will use the cash to launch phase 2/3 clinical trials of its immunotherapy candidate.

CureFit Healthcare has raised funding from investors including the UC-RNT fund, a venture capital vehicle established by University of California with Ratan Tata.

CSL Behring has agreed to acquire Calimmune, a developer of gene therapy treatments that is backed by an unnamed pharmaceutical firm.

Legend Capital has celebrated an exit as Berry Genomics completed a reverse merger with Chengdu Tianxing Instrument and Meter in a deal worth $653m.

Boston Scientific, Medtronic and GlaxoSmithKline returned to support a $30m series D round for biomedical technology company SetPoint Medical.